Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.902
0.00 (0.00%)
Jul 17, 2026, 5:35 PM CET
Oryzon Genomics Employees
Oryzon Genomics had 46 employees as of December 31, 2025. The number of employees decreased by 1 or -2.13% compared to the previous year.
Employees
46
Change
-1
Growth
-2.13%
Revenue / Employee
€237,705
Profits / Employee
€48,571
Market Cap
237.84M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 46 | -1 | -2.13% |
| Jun 30, 2025 | 47 | - | - |
| Dec 31, 2024 | 47 | 1 | 2.17% |
| Dec 31, 2023 | 46 | 2 | 4.78% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 1 | 1.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Grifols | 25,000 |
| Faes Farma | 2,681 |
| Almirall | 2,108 |
| Laboratorios Farmaceuticos Rovi | 2,045 |
| Clínica Baviera | 1,910 |
| Laboratorio Reig Jofre | 1,400 |
| Prim, S.A. | 984 |
| Atrys Health | 758 |
Oryzon Genomics News
- 6 weeks ago - Oryzon Genomics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026 - GlobeNewsWire
- 2 months ago - Oryzon Genomics Earnings release: Q1 2026 - Filings
- 2 months ago - ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026 - GlobeNewsWire
- 4 months ago - Oryzon Genomics announces patent grant decision in Mexico - TheFly
- 4 months ago - Oryzon Genomics Slides: Corporate presentation - Filings
- 5 months ago - ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025 - GlobeNewsWire
- 5 months ago - Oryzon Genomics Earnings release: Q4 2025 - Filings